Astrazeneca, the British – Swedish drug maker, has joined forces with the UK government to support the Oxford University to develop a coronavirus vaccine. The partnership is one the most closely watched vaccine efforts.
AstraZeneca has signed agreements with governments around the world to supply the vaccine should it prove effective and gain regulatory approval. It has said it will not seek to profit from the vaccine during the pandemic.
Update! In July, the developers released results saying their vaccines had produced strong immune responses with only minor side effects. The results, published in the British medical journal The Lancet, found the vaccine generated both antibody and T-cell immune responses, which are hoped to be key to stopping an infection.
There is still a long way to go but it looks promising.